SYT13 and metastatic malignant neoplasm in the lymph nodes: There were no significant differences of SYT13 mRNA expression levels between Tis/T1 (n = 77) and T2/T3/T4 (n = 88; p = 0.424), lymph node metastasis-positive (n = 80) and negative (n = 85; p = 0.303), or stage 0/I/II (n = 131) and stage III/IV (n = 34; p = 0.732).